cas 3398-16-1|| where to buy 4-bromo-3,5-dimethyl-1H-pyrazole

Nom du produit:4-bromo-3,5-dimethyl-1H-pyrazole

IUPAC Name:4-bromo-3,5-dimethyl-1H-pyrazole

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM112771-500g	in stock	Ǫȃľ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 3398-16-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:3398-16-1; Formule moléculaire:C5H7BrN2; Point de fusion:-; Code SMILES:CC1=C(Br)C(C)=NN1; Densité:

: Numéro de catalogue:CM112771; Poids moléculaire:175.03; Point d'ébullition:341°C at 760 mmHg; N° Mdl:MFCD00005242; Stockage:Store at 2-8°C.

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Povorcitinib; Incyte announced results from a Phase 2 study evaluating the efficacy and safety of povorcitinib, an oral JAK1 inhibitor, in adult patients with prurigo nodularis (PN). These data were presented as a late-breaking oral presentation at the American Academy of Dermatology (AAD) Annual Meeting.
Povorcitinib (INCB54707) is an oral small-molecule JAK1 inhibitor currently in Phase 3 clinical trials for hidradenitis suppurativa (HS) and vitiligo. A Phase 3 trial is being planned for PN.